tlooto
Sign up
Medicine

Is There a Benefit of HER2-Positive Breast Cancer Subtype Determination in Clinical Practice?

I. Kolářová, J. Vaňásek, K. Odrážka, L. Dušek, Z. Sinkorova, A. Hlávka, J. Stuk, J. Stejskal, D. Dvorakova, L. Sákra, J. Mergancová, Z. Vilasová

2019.2.15Klinicka Onkologie

DOI: 10.14735/amko201925

Abstract

Abstract is not available.

Citation format

KOLÁŘOVÁ, I., et al. Is there a benefit of her2-positive breast cancer subtype determination in clinical practice? Klinicka Onkologie, 2019.